MétaCan
Menu
Back to cohort
Record W4396592399 · doi:10.1093/neuonc/noae082

Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients

2024· review· en· W4396592399 on OpenAlexaff
Justin Z. Wang, Alexander Landry, David R. Raleigh, Felix Sahm, Kyle M. Walsh, Roland Goldbrunner, Leeor S. Yefet, Jörg C. Tonn, Chloe Gui, Quinn T. Ostrom, Jill S. Barnholtz‐Sloan, Arie Perry, Yosef Ellenbogen, C. Oliver Hanemann, Gerhard Jungwirth, Michael D. Jenkinson, Ghazaleh Tabatabai, Tiit Mathiesen, Michael McDermott, Marcos Tatagiba, Christian la Fougère, Sybren L. N. Maas, Norbert Galldiks, Nathalie L. Albert, Priscilla K. Brastianos, Felix Ehret, Giuseppe Minniti, Katrin Lamszus, Franz Ricklefs, Jens Schittenhelm, Katharine J. Drummond, Ian F. Dunn, Omar Pathmanaban, Aaron Cohen‐Gadol, Erik P. Sulman, Émeline Tabouret, Emelie Le Rhun, Christian Mawrin, Jennifer Moliterno, Michael Weller, Wenya Linda Bi, Andrew Gao, Stephen Yip, Maximilian Niyazi, Kenneth Aldape, Patrick Y. Wen, Susan Short, Matthias Preusser, Farshad Nassiri, Gelareh Zadeh

Bibliographic record

VenueNeuro-Oncology · 2024
Typereview
Languageen
FieldMedicine
TopicMeningioma and schwannoma management
Canadian institutionsPrincess Margaret Cancer CentreUniversity of TorontoUniversity of British ColumbiaUniversity Health Network
FundersNational Cancer Institute
KeywordsMeningiomaConsensus conferenceMedicineMedical physicsLibrary scienceComputer sciencePathologyInternal medicine

Abstract

fetched live from OpenAlex

Meningiomas are the most common primary intracranial tumors in adults and are increasing in incidence due to the aging population and increased access to neuroimaging. While most exhibit nonmalignant behavior, a subset of meningiomas are biologically aggressive and are associated with treatment resistance, resulting in significant neurologic morbidity and even mortality. In recent years, meaningful advances in our understanding of the biology of these tumors have led to the incorporation of molecular biomarkers into their grading and prognostication. However, unlike other central nervous system (CNS) tumors, a unified molecular taxonomy for meningiomas has not yet been established and remains an overarching goal of the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy-Not Official World Health Organization (cIMPACT-NOW) working group. Additionally, clinical equipoise still remains on how specific meningioma cases and patient populations should be optimally managed. To address these existing gaps, members of the International Consortium on Meningiomas including field-leading experts, have prepared this comprehensive consensus narrative review directed toward clinicians, researchers, and patients. Included in this manuscript are detailed overviews of proposed molecular classifications, novel biomarkers, contemporary treatment strategies, trials on systemic therapies, health-related quality-of-life studies, and management strategies for unique meningioma patient populations. In each section, we discuss the current state of knowledge as well as ongoing clinical and research challenges to road map future directions for further investigation.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.017
metaresearch head score (Gemma)0.037
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.017
Threshold uncertainty score0.088

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0170.037
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0020.002
Bibliometrics0.0060.005
Science and technology studies0.0010.001
Scholarly communication0.0040.003
Open science0.0030.004
Research integrity0.0050.004
Insufficient payload (model declined to judge)0.0050.004

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.188
GPT teacher head0.465
Teacher spread0.277 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations134
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueNeuro-OncologySame topicMeningioma and schwannoma managementFrench-language works237,207